EUVIMEDEUVIMED entdecken
Crossref

Pre-ligand assembly domain-derived recombinant protein of TNFR2 inhibits the expansion of CD4+ Foxp3+ regulatory T cells

Wen-Wei Li, Chuangen Li, Yang Yang, Yibo Chen, Zhonghao Chen, Yang Gao, Yiru Wang, Tao Liu, Xin Chen, Chon-Kit Chou iD

Journal of Leukocyte Biology · 2025

DOI: 10.1093/jleuko/qiaf087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Wen-Wei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Ta…. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Type II, T-Lymphocytes, Regulatory, Recombinant Proteins, Forkhead Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is compelling evidence that tumor necrosis factor (TNF) receptor type II (TNFR2) mediates the stimulatory effect of TNF on the activation of CD4+ Foxp3+ regulatory T cells (Tregs). Tregs with high TNFR2 expression are critical components of tumor microenvironment, where they promote tumor progression by impeding antitumor immune responses. Thus, selectively targeting TNFR2 has emerged as a promising strategy to inhibit Treg activity and enhance antitumor immune responses. The preligand-binding assembly domain (PLAD) is a conserved extracellular domain that subtly differs among TNF receptor family members, facilitating the ligand-independent assembly of receptor monomers into a spatially optimal trimer that favors ligand binding. Previous studies demonstrated that recombinant PLAD proteins derived from TNFR1 were able to inhibit TNFR1-mediated cell death and alleviated inflammatory conditions in mouse models. However, the functional properties of TNFR2-derived PLAD remain largely unexplored. In this study, we developed recombinant PLAD proteins from human and mouse TNFR2, as well as TNFR1, and evaluated their ability to interfere with TNF binding and Treg activation. All 4 PLAD proteins dose-dependently inhibited TNF-stimulated NF-κB transcriptional activity in HEK293 reporter cells. Among them, human TNFR2-derived PLAD exhibited relatively enhanced inhibitory effects compared with the other 3 in HEK293 reporter cells overexpressing TNFR2 but lacking TNFR1, and potently blocked TNF binding to TNFR2 on Jurkat cell surfaces. Furthermore, human TNFR2-derived PLAD significantly reduced the TNF-induced proliferative expansion of CD4+ Foxp3+ Tregs in both mouse lymphocyte and human peripheral blood mononuclear cell cultures. Our findings suggest that human TNFR2-derived PLAD merits further investigation for the cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Tumor Necrosis Factor, Type IIT-Lymphocytes, RegulatoryRecombinant ProteinsForkhead Transcription FactorsAnimalsHumansMiceCell ProliferationProtein DomainsReceptors, Tumor Necrosis Factor, Type INF-kappa BHEK293 CellsLigandsLymphocyte Activation

Stichwörter der Autor:innen

PLADTNFR2Tregscancer immunotherapypreligand-binding assembly domain

Substanzen

Receptors, Tumor Necrosis Factor, Type IIRecombinant ProteinsForkhead Transcription FactorsFOXP3 protein, humanReceptors, Tumor Necrosis Factor, Type INF-kappa BLigands

Autor:innen und Institutionen

  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau SAR, 999078, China.
  • Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, 32 West 7th Avenue, Tianjin Airport Economic Area, Tianjin 300308, China.
  • UM-TIB Joint Laboratory of Synthetic Biology for Traditional Chinese Medicine, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, 32 West 7th Avenue, Tianjin Airport Economic Area, Tianjin 30030…
  • National Center of Technology Innovation for Synthetic Biology, 32 West 7th Avenue, Tianjin Airport Economic Area, Tianjin 300308, China.
  • Department of Pharmaceutical Science, Faculty of Health Sciences, University of Macau, Avenida da Universidade, Taipa, Macau SAR, 999078, China.
  • MoE Frontiers Science Center for Precision Oncology, University of Macau, Avenida da Universidade, Taipa, Macau SAR, 999078, China.

ORCID-Profile: Chon-Kit Chou

Zitieren

APA

Li, W. W., Li, C., Yang, Y., Chen, Y., Chen, Z., Gao, Y., Wang, Y., Liu, T., Chen, X., & Chou, C. K. (2025). Pre-ligand assembly domain-derived recombinant protein of TNFR2 inhibits the expansion of CD4+ Foxp3+ regulatory T cells. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiaf087

Vancouver

Li WW, Li C, Yang Y, Chen Y, Chen Z, Gao Y, et al. Pre-ligand assembly domain-derived recombinant protein of TNFR2 inhibits the expansion of CD4+ Foxp3+ regulatory T cells. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiaf087

BibTeX
@article{Li2025,
  author = {Li, Wen-Wei and Li, Chuangen and Yang, Yang and Chen, Yibo and Chen, Zhonghao and Gao, Yang and Wang, Yiru and Liu, Tao and Chen, Xin and Chou, Chon-Kit},
  title = {Pre-ligand assembly domain-derived recombinant protein of TNFR2 inhibits the expansion of CD4+ Foxp3+ regulatory T cells},
  journal = {Journal of Leukocyte Biology},
  year = {2025},
  doi = {10.1093/jleuko/qiaf087}
}
Kostenlos starten →